Advertisement

Low anti-anxiety hormone levels may increase postpartum depression, says study

A new study has shown that pregnant women having low levels of anti-anxiety hormone in their second trimester may have high risk of developing postpartum depression.

Low anti-anxiety hormone levels may increase postpartum depression, says study Image for representational purpose only

New York: A new study has shown that pregnant women having low levels of anti-anxiety hormone in their second trimester may have high risk of developing postpartum depression.

Postpartum depression is a depression that occurs after childbirth and affects early bonding between the mother and child.

As per the study, appearing in the journal Psychoneuroendocrinology, a woman with an allopregnanolone hormone level of about 3.75 nanograms per milli-liter had a 33 per cent likelihood of developing the disorder.

While a woman having 7.5 nanograms per milli-liter had a 1.5 per cent chance of developing postpartum depression.

Researchers said that for every additional nanogram per milli-liter increase in allopregnanolone, the risk of developing postpartum depression dropped by 63 per cent.

And the risk was particularly high in women already diagnosed with mood disorders, such as major depression or bipolar disorder.

Lauren M. Osborne, Assistant Professor at the Johns Hopkins University in Maryland, US said, "Many earlier studies haven't shown postpartum depression to be tied to actual levels of pregnancy hormones, but rather to an individual's vulnerability to fluctuations in these hormones and they didn't identify any concrete way to tell whether a woman would develop postpartum depression".

Osborne added, "Every woman has high levels of certain hormones, including allopregnanolone, at the end of pregnancy, so we decided to look earlier in the pregnancy to see if we could tease apart small differences in hormone levels that might more accurately predict postpartum depression later".

For the study, the team included 60 pregnant women between the ages of 18 and 45, all who had been previously diagnosed with a mood disorder.

Using the blood samples, the researchers measured the blood levels of progesterone and allopregnanolone, a by-product made from the breakdown of progesterone and known for its calming, anti-anxiety effects.

No relationship was found between progesterone levels in the second or third trimesters and the likelihood of developing postpartum depression.

However, a link between postpartum depression and diminished levels of allopregnanolone levels in the second trimester was observed.

(With IANS inputs)